foxo4-dri human trial senolytic Development of a novel by precise disruption of FOXO4-p53 complex FOXO4-DRI 10mg vial - Description

Effect of epithalon on the incidence of chromosome aberrations in senescence-accelerated mice

These are the same mechanisms that traditional immunotherapy uses, but peptide immunotherapy appears to achieve them faster and with fewer risks

Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk

2001